Dr Lal PathLabs
About Me
Dr Lal PathLabs
DM
Hematologists
10 Years Experience
Biography
My Clinic
OPD Hours
| Monday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Tuesday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Wednesday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Thursday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Friday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Saturday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM | |
| Sunday | Morning | 10:00 AM | - | 02:00 PM |
| Evening | 06:00 PM | - | 09:00 PM |
Treatments
Specialised care and treatments offered
SICKLE CELL DISEASE MANAGEMENT
Sickle cell disease (SCD) is a genetic disorder characterized by abnormally shaped red blood cells that can lead to severe pain crises and complications affecting health. Effective management focuses on preventing crises while promoting overall wellness among affected individuals through comprehensive care plans tailored specifically towards their needs throughout their lifespan.
- Common manifestations might involve chronic pain episodes associated mainly with vaso-occlusive events alongside acute chest syndromes requiring prompt attention from healthcare professionals when they arise.
- Diagnosis relies predominantly upon newborn screening programs initiated soon after birth followed up via confirmatory testing methods assessing hemoglobin variants directly present within samples collected.
- Treatment modalities range widely depending upon severity—including hydroxyurea usage known traditionally used amongst adults aiming at decreasing frequency/intensity linked directly tied back toward painful events arising unpredictably within everyday lives involved here.
- Supportive interventions including regular check-ups for vaccinations essential needed protecting individuals further throughout growth periods extending into adulthood should not be overlooked either!
The combination approach allows those living with SCD improved quality outcomes coupled alongside enhanced experiences enhancing daily interactions safely without pushing boundaries too hard pushing limits unnecessarily—resulting long-term betterment healthier futures!
COAGULATION DISORDER TREATMENT
Treatment for coagulation disorders includes addressing issues related to bleeding tendencies caused by abnormalities in clotting factor levels. Conditions like hemophilia require ongoing management practices tailored specifically towards maintaining safe levels of clotting factors in circulation.
- Patients may present with symptoms such as excessive bleeding during injuries or spontaneous bruising without apparent cause.
- A thorough assessment involving family history review and laboratory tests including clotting profiles guides diagnosis effectively.
- Treatment typically consists of replacement therapies using factor concentrates derived from donated plasma or recombinant sources which help minimize bleeding risks significantly over time.
- Additional management strategies may also involve lifestyle modifications alongside preventative measures against potential bleeds during invasive procedures.
By adhering closely to recommended therapies; most individuals manage their coagulation disorders successfully while enjoying active lives.
HEMOGLOBIN DISORDERS MANAGEMENT
Management of hemoglobin disorders encompasses strategies aimed at treating abnormalities like thalassemia and sickle cell disease. These inherited conditions result from mutations affecting hemoglobin's structure and function, often leading to severe health issues if left untreated.
- Symptoms may include chronic pain crises, anemia-related fatigue, and increased risk of infections due to spleen dysfunctions associated with these disorders.
- Diagnosis relies on genetic testing as well as hemoglobin electrophoresis to identify specific anomalies within hemoglobin types.
- Treatment management could involve regular blood transfusions, iron chelation therapy for patients receiving repeated transfusions, or newer targeted therapies aimed at modifying disease symptoms on a molecular level.
This comprehensive approach helps improve symptoms significantly while enhancing life expectancy for those affected by these conditions.
THERAPEUTIC APHERESIS
Therapeutic apheresis refers to processes designed to remove harmful substances from the bloodstream. This can be particularly effective in managing conditions like hyperviscosity syndromes or certain autoimmune diseases where excess antibodies are an issue.
- This treatment may alleviate symptoms caused by high levels of abnormal proteins in the blood that affect circulation and organ function.
- Prior to treatment, healthcare providers will assess the patient's condition through clinical evaluations and lab tests to determine suitability.
- The procedure involves using specialized machines that separate blood components; unwanted elements are removed while red blood cells are returned to the body.
- Apheresis generally entails minimal side effects; however, some patients may experience temporary fatigue post-procedure due to fluid shifts within their system.
With therapeutic apheresis, patients often see significant improvement in their overall well-being and quality of life.
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Peripheral blood stem cell transplantation (PBSCT) is a therapeutic option utilized in treating various blood cancers and disorders. This innovative approach harnesses stem cells from your bloodstream to restore healthy blood production after high-dose chemotherapy or radiation therapy.
- Common indications for PBSCT include conditions like lymphoma and multiple myeloma.
- The extraction process involves collecting stem cells from a donor or the patient themselves, typically through apheresis techniques.
- Treatment often requires pre-conditioning regimens to prepare the patient’s body for transplant.
- The success of this therapy depends on careful matching of donors and patients along with post-transplant care, which includes monitoring and management of potential complications such as graft-versus-host disease (GVHD).
This advanced treatment offers hope for many patients facing serious hematologic disorders.
BONE MARROW BIOPSY
A bone marrow biopsy is a procedure that involves the extraction of bone marrow for examination, primarily used to diagnose blood-related conditions. This diagnostic tool is crucial for identifying various disorders such as leukemia or anemia and can guide treatment decisions.
- Symptoms that may lead to this procedure include unexplained fatigue, frequent infections, or easy bruising.
- The diagnosis is usually confirmed through imaging studies followed by the biopsy itself, allowing for direct observation of marrow health.
- Treatment options can vary based on findings; they may include medications, chemotherapy, or other therapies if malignancy is detected.
- During the procedure, patients may experience mild discomfort but are generally able to return home the same day.
- Aftercare involves monitoring for any signs of complications, such as infection or bleeding at the site of the biopsy.
This procedure provides essential insights into your hematological health and assists in crafting tailored treatment plans.